![]() |
Name |
phytotoxic nordammarane triterpenoid helvolic acid
|
Molecular Formula | C35H50O8 | |
IUPAC Name* |
2-(6,16-diacetyloxy-4,8,10,14-tetramethyl-3,7-dioxo-5,6,9,11,12,13,15,16-octahydro-4H-cyclopenta[a]phenanthren-17-ylidene)-6-methylhept-5-enoicacid;ethane
|
|
SMILES |
CC.CC(=O)OC1CC2(C)C(CCC3C4(C)C=CC(=O)C(C)C4C(OC(C)=O)C(=O)C32C)C1=C(CCC=C(C)C)C(=O)O
|
|
InChI |
InChI=1S/C33H44O8.C2H6/c1-17(2)10-9-11-21(30(38)39)26-22-12-13-25-31(6)15-14-23(36)18(3)27(31)28(41-20(5)35)29(37)33(25,8)32(22,7)16-24(26)40-19(4)34;1-2/h10,14-15,18,22,24-25,27-28H,9,11-13,16H2,1-8H3,(H,38,39);1-2H3/b26-21-;/t18-,22?,24+,25+,27?,28+,31-,32+,33-;/m1./s1
|
|
InChIKey |
NFBZAVATAYITJA-OEDOGJQSSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 598.78 | ALogp: | 6.4 |
HBD: | 1 | HBA: | 7 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 124.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 43 | QED Weighted: | 0.212 |
Caco-2 Permeability: | -5.302 | MDCK Permeability: | 0.00001880 |
Pgp-inhibitor: | 0.902 | Pgp-substrate: | 0.736 |
Human Intestinal Absorption (HIA): | 0.533 | 20% Bioavailability (F20%): | 0.793 |
30% Bioavailability (F30%): | 0.726 |
Blood-Brain-Barrier Penetration (BBB): | 0.929 | Plasma Protein Binding (PPB): | 96.80% |
Volume Distribution (VD): | 0.627 | Fu: | 5.48% |
CYP1A2-inhibitor: | 0.004 | CYP1A2-substrate: | 0.077 |
CYP2C19-inhibitor: | 0.016 | CYP2C19-substrate: | 0.748 |
CYP2C9-inhibitor: | 0.032 | CYP2C9-substrate: | 0.104 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.043 |
CYP3A4-inhibitor: | 0.339 | CYP3A4-substrate: | 0.332 |
Clearance (CL): | 2.167 | Half-life (T1/2): | 0.162 |
hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.234 |
Drug-inuced Liver Injury (DILI): | 0.421 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.95 | Maximum Recommended Daily Dose: | 0.68 |
Skin Sensitization: | 0.034 | Carcinogencity: | 0.298 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.051 |
Respiratory Toxicity: | 0.972 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001480 | ![]() |
0.973 | D0X7XG | ![]() |
0.465 | ||
ENC003484 | ![]() |
0.882 | D0G7KJ | ![]() |
0.289 | ||
ENC003780 | ![]() |
0.805 | D01ZOG | ![]() |
0.267 | ||
ENC005154 | ![]() |
0.784 | D08BDT | ![]() |
0.265 | ||
ENC005236 | ![]() |
0.784 | D0H2MO | ![]() |
0.262 | ||
ENC002467 | ![]() |
0.768 | D0X2LV | ![]() |
0.262 | ||
ENC005155 | ![]() |
0.730 | D09IEE | ![]() |
0.261 | ||
ENC003848 | ![]() |
0.697 | D09WYX | ![]() |
0.258 | ||
ENC003846 | ![]() |
0.618 | D0D2TN | ![]() |
0.250 | ||
ENC005153 | ![]() |
0.616 | D0OL7F | ![]() |
0.247 |